BBIO
BridgeBio Pharma, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #918
- Final score
- 18.46
- Years on list
- 1
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 242 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↘ Down 570 since 2023
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | BBIO | EXEL | ROIV |
|---|---|---|---|
| Climate Change | 19.8 | 27.0 | 15.7 |
| Employee Relations | 28.0 | 33.6 | 24.6 |
| Environment | 7.4 | 18.4 | 12.5 |
| Stakeholders & Society | 14.5 | 19.3 | 19.3 |
| Human Rights | 11.8 | 4.7 | 2.5 |
| Governance | 25.9 | 28.5 | 24.7 |
| Performance Rating | 29.0 | 52.0 | 45.8 |